Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000721179 | SCV000852123 | uncertain significance | Phenylketonuria | 2019-04-26 | reviewed by expert panel | curation | PAH-specific ACMG/AMP criteria applied: PM2: Extremely low frequency. ESP MAF=0.00012.; PP4_Moderate: Detected in a patient with mild HPA. Assessment of the PAH, PTS, and QDPR genes was performed. (PMID:21147011); PM3-supporting: Detected with V388M, pathogenic in ClinVar, but parental testing not performed. (PMID:21147011). In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP4_Moderate, PM3_supporting). |
Eurofins Ntd Llc |
RCV000078515 | SCV000110371 | uncertain significance | not provided | 2015-09-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000078515 | SCV001250398 | likely pathogenic | not provided | 2019-11-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000721179 | SCV002796344 | uncertain significance | Phenylketonuria | 2022-02-03 | criteria provided, single submitter | clinical testing |